Abbott Labs board OKs $7 billion stock buyback program
Medical device giant Abbott Laboratories is launching a $7 billion stock buyback program. The repurchase of common shares was approved by Abbott’s board of directors this month, the North Chicago-based company announced today in conjunction with revealing its third-quarter earnings.
US companies boosted their stock buyback plans this year, amidrising profits and excess cash. According to data from EPFR, ...
The board of Ulta Beauty has approved a $3 billion share repurchase authorization as it prepares to open 200 net new stores over the next three years. The specialty cosmetics retailer said Wednesday ...
Buybacks are popular in a hot stock market as concerns about a potential increase to the 1% buyback tax heat up Companies have been feverishly announcing plans to buy back their own stock this ...
City Hall may have disqualified itself from getting millions in federal housing dollars. Crain’s residential real estate ...
The Winnipeg, Manitoba-based packaging solutions said Thursday that the Toronto Stock Exchange has accepted the amendment to increase the maximum number of shares it can repurchase under its current ...
Financial writer rates JD as a Buy due to China's economic revival efforts, management improvements, and attractive valuation ...
Germany’s RWE AG management should provide clarity on whether a share buyback program will be extended at scale or rule it ...
Microsoft recently announced a stock buyback and dividend hike. Does this news make MSFT stock a potential buy?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback